HJLI News and Press, Hancock Jaffe Laboratories Inc. From 03/21/19

Implantations to Take Place by End of April with Initial Data Expected in June 2019 IRVINE, CA / ACCESSWIRE / March 21, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a developer of medical devices that restore cardiac and vascular health, has enrolled four additional patient...

PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +108%  on positive PB2452 data . More news on: PhaseBio Pharmaceuticals, Inc., Dermira, Inc., Leap Therapeutics, Inc., Stocks on the move, Read more ...

Excellent Initial Flow Rates Achieved with CoreoGrafts for Bypasses Completed in Two Test Subjects IRVINE, CA / ACCESSWIRE / March 18, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, today announce...

CORAL GABLES, FL / ACCESSWIRE / March 14, 2019 / Over the last few months, the healthcare stock market has captivated media attention as companies in the healthcare sector have focused their efforts on developing innovative treatment options and care solutions for patients suffering from a...

Gainers: Atossa Genetics (NASDAQ: ATOS ) +242% . Hancock Jaffe Laboratories (NASDAQ: HJLI ) +41% . WageWorks (NYSE: WAGE ) +30%.  Smith Micro Software (NASDAQ: SMSI ) +31% . Akari Therapeutics (NASDAQ: AKTX ) +30% . KalVista Pharmaceuticals (NASDAQ: KALV ) +29% . MongoDB (NASDA...

Atossa Genetics (NASDAQ: ATOS ) +223%  on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...

Hancock Jaffe Laboratories (NASDAQ: HJLI ): FY GAAP EPS of -$1.75. More news on: Hancock Jaffe Laboratories, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

Company Strengthens Financial Position Ahead of Key Milestones IRVINE, CA / ACCESSWIRE / March 13, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, has closed a private placement of 2,360,051 shares...

IRVINE, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a Company specializing in medical devices that restore cardiac and vascular health, today announced the successful start of its VenoValve ®  first-in-human study in Bogota, Co...

Fortress Biotech (NASDAQ: FBIO ) +56%  on Caelum deal with Alexion. More news on: Fortress Biotech, Inc., Prana Biotechnology Ltd, VistaGen Therapeutics, Inc., Stocks on the move, , Read more ...